tritace tablets
sanofi-aventis s.p.a. - ramipril - tablets - 5mg
tritace tablets
sanofi-aventis s.p.a. - ramipril - tablets - 2,5mg
spasmomen tablets film-coated
berlin-chemie a.g. - otilonium bromide - tablets film-coated - 40mg
yarina plus 3mg+30mcg+451mcg tablets film-coated
bayer weimar gmbh & co. kg - drospirenone, ethinylestradiol, levomefolate calcium - tablets film-coated - 3mg+30mcg+451mcg
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
amaryl (m) 250 mg, 1 mg
شركة ألفه للأدوية - ulfa pharma co. - metformin hcl 250 mg, glimepiride 1 mg - 250 mg, 1 mg
symbicort turbuhaler 160 mcg/dose, dihydrate 4.5 mcg/dose
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - budesonide 160 mcg/dose, formoterol fumarate dihydrate 4.5 mcg/dose - 160 mcg/dose, dihydrate 4.5 mcg/dose
symbicort turbuhaler 160 mcg/dose, dihydrate 4.5 mcg/dose
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - budesonide 160 mcg/dose, formoterol fumarate dihydrate 4.5 mcg/dose - 160 mcg/dose, dihydrate 4.5 mcg/dose
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1).
trixeo aerosphere
astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium - suspension for inhalation - formoterol fumarate dihydrate 5 mcg; glycopyrronium 7.2 mcg; budesonide 160 mcg - budesonide - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist